Domů › Rakovina vaječníků › North Carolina › Durham
Klinické studie Rakovina vaječníků v Durham, NC
27 studií pro Rakovina vaječníků hledá účastníky v lokalitách v Durham a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Probíhá náborFáze 2/3
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
- University of North Carolina-Hillsborough Campus, Hillsborough · Vzdálenost 13 mi
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- Duke University Medical Center, Durham
A Study of PHST001 in Advanced Solid Tumors
Probíhá náborFáze 1
- Duke Cancer Institute, Durham
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- Duke University, Durham
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Probíhá náborFáze 2
- University of North Carolina Medical Center /ID# 275307, Chapel Hill · Vzdálenost 10 mi
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Probíhá náborFáze 2
- Site 0259 - Duke Cancer Center, Durham
DESTINY-PANTUMOUR04
Probíhá náborObservační studie
- Research Site, Durham
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Probíhá náborFáze 3
- Duke Cancer Institute, Durham
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Probíhá náborFáze 1
- Duke University Medical Center, Durham
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Probíhá náborFáze 3
- Duke Cancer Center ( Site 0012), Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Probíhá náborObservační studie
- UNC- Chapel Hill, Chapel Hill · Vzdálenost 10 mi
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Probíhá náborFáze 3
- Duke, Durham
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Probíhá nábor
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Probíhá náborFáze 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Probíhá náborFáze 1/2
- Duke University, Durham
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Probíhá náborFáze 3
- UNC Hospital, Chapel Hill · Vzdálenost 10 mi
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Probíhá náborFáze 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · Vzdálenost 10 mi
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Probíhá náborFáze 3
- Duke Cancer Center, Durham
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Probíhá nábor
- Duke Cancer Center, Durham
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Probíhá náborFáze 1
- Site 0259, Durham
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Probíhá nábor
- Duke University Hospital, Durham
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Probíhá náborFáze 1/2
- Duke Cancer Center/ DUMC, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- Duke Cancer Institute, Durham
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Probíhá náborFáze 2
- Duke Cancer Center, Durham
Multimedia Aid for Genetic Testing in Gynecologic Oncology
Probíhá nábor
- Univeristy of North Carolina at Chapel Hill, Chapel Hill · Vzdálenost 10 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Chapel Hill · Vzdálenost 10 mi
Studie Rakovina vaječníků v jiných městech
- Houston, TX89 studií
- New York City, NY69 studií
- Boston, MA61 studií
- Los Angeles, CA50 studií
- Nashville, TN49 studií
- Arlington, VA46 studií
- Philadelphia, PA44 studií
- Columbus, OH39 studií
- St. Louis, MO38 studií
- Chicago, IL36 studií
- San Antonio, TX31 studií
- Cleveland, OH30 studií
Další studie v Durham
- Rakovina prsu64 studií
- Rakovina (všechny typy)58 studií
- Nemalobuněčný plicní karcinom39 studií
- Mnohočetný myelom37 studií
- Akutní myeloidní leukemie33 studií
- Metastatický karcinom33 studií
- Rakovina prostaty32 studií
- Rakovina plic32 studií
- Kolorektální karcinom28 studií
- Chronická lymfocytární leukemie27 studií
- Srdeční selhání26 studií
- Rakovina slinivky břišní24 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.